Health
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera – Science
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B1.1.7 (VOC 202012/01) variant that emerged in late 2020 in the United Kingdom has many changes…
Abstract
Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage called B.1.1.7 (variant of concern: VOC 202012/01), which is reported to spread more efficiently and faster than other strains, emerged in the United Kingdom. This variant has an unusually large number of mutations, with 10 amino acid changes in the spike (S) protein, raising concerns that its recognition by neutralizing antibodies may be affected. In this study, we tested SARS-CoV-2-S pseudoviruses bearing…
-
Noosa News21 hours agoEx-Townsville mayor Troy Thompson lied about army service, degrees, and cancer, says CCC
-
Noosa News21 hours agoSecurity concerns over Chinese-made Yutong fleet dismissed
-
Noosa News23 hours agoQueensland’s domestic violence policing and policies are being shaped by lived experience
-
Noosa News13 hours agoQueensland’s ‘promising’ coercive control laws see more than 50 charges laid in six months since criminalisation